Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist

Molecular Brain Research

Volumn 61, Issue 1-2, 1998, Pages 219-223

  Van De Witte, Serge V ^a   Drukarch, Benjamin ^a   Stoof, Johannes C ^a   Voorn, Pieter ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

6 hydroxydopamine; Basal ganglia; Dopamine receptor; In situ hybridization; Sensitization; Turning behavior

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE DERIVATIVE; DYNORPHIN; LEVODOPA; MESSENGER RNA; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

EID: 0032582449     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00214-9     Document Type: Article

References (22)

1. Alexander G.E., De Long M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
2. Alexander G.E., Crutcher M.D. Functional architecture of basal ganglia circuits neuronal substrates of parallel processing. Trends Neurosci. 13:1990;266-271.
3. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc. Natl. Acad. Sci. USA. 94:1997;3363-3367.
4. Carey R.J. Chronic L-DOPA treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res. 568:1991;205-214.
5. Carey R.J., Pinheiro-Carrera M., Tomaz C., Huston J.P. Early L-DOPA treatment initially retards but later enhances dopamine receptor supersensitivity following unilateral dopamine denervation. Brain Res. 658:1994;145-154.
6. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. USA. 82:1985;4291-4295.
7. Engber T.M., Susel Z., Juncos J.L., Chase T.N. Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonist. Eur. J. Pharmacol. 168:1989;291-298.
8. Engber T.M., Susel Z., Kuo S., Gerfen C.R., Chase T.N. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Brain Res. 552:1991;113-118.
9. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
10. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15:1992;285-320.
11. Granata R., Wenning G.K., Jolkkonen J., Jenner P., Marsden C.D. Effect of repeated administration of dopamine agonist on striatal neuropeptide mRNA expression in rats with a unilateral nigral 6-hydroxydopamine lesion. J. Neural. Transm. 103:1996;249-260.
12. Jolkkonen J., Granata R., Jenner P., Marsden C.D. Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in rat striatum. Neuropeptides. 29:1995;109-114.
13. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc. Natl. Acad. Sci. USA. 84:1987;881-885.
14. McEwen B.S., Angulo J.A. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 1:1994;1-28.
15. Morelli M., Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Eur. J. Pharmacol. 141:1987;101-107.
16. Morelli M., Fenu S. Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses. Neuroscience. 53:1993;673-678.
17. Paul M.L., Currie R.W., Robertson H.A. Priming of a dopamine receptor behavioral response is dissociated from striatal immediate-early gene activity. Neuroscience. 66:1995;347-359.
18. G. Paxinos, C. Watson, The Rat Brain in Stereotactic Coordinates, 2nd edn. Academic Press, Sydney, 1986.
19. Schwarting R.K.W., Bonatz A.E., Carey R.J., Huston J.P. Relationships between indices of behavioral asymmetries and neuronal changes following mesencephalic 6-hydroxydopamine injections. Brain Res. 554:1991;46-55.
20. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J. Biol. Chem. 259:1984;14301-14308.
21. W.S. Young, In situ hybridization histochemistry. In: F.G. Wouterlood, A.N. Van der Pol (Eds.), Methods for the Study of Neuronal Microcircuits and Synaptic Interactions. Handbook of Chemical Neuroanatomy, Elsevier Science Publishers, Amsterdam, 1990, pp. 481-512.
22. Zeng B.Y., Jolkkonen J., Jenner P., Marsden C.D. Chronic L-DOPA treatment differentially regulates gene expression of glutamate decarboxylase, preproenkephalin and preprotachykinin in the striatum of 6-hydroxydopamine-lesioned rat. Neuroscience. 66:1995;19-28.